SurgLine International Inc. (PINK: SGLN), a distributor of high quality FDA approved medical and surgical products at discount prices, today, announced that it acquired Eden Surgical Technologies LLC.
A Texas Limited Liability Company, Eden distributes trauma products. Commenting on the development, Thomas Toland, CEO of SurgLine, said that SGLN is pleaded to announce that it acquired Eden Surgical Technologies pursuant to a Share Exchange Agreement in exchange of 50 million shares of restricted common stock of the company.
Toland said that the acquisition of Eden will substantially expand SGLN’s line of trauma products while providing the company with pricing which will give it a competitive advantage in the marketplace. Toland added that SGLN will have an immediate access to products that are crucial to its acute care hospital clients in particular.
SGLN shares are seeing huge activity in trading today. At last check, the stock was trading at $0.0009 on volume of 4.95 million.
Recent Comments